Grifols announces positive topline phase 3 fibrinogen clinical trial results
In the AdFIrst study, Biotest’s fibrinogen concentrate (FC), BT524, met the primary endpoint, demonstrating its effectiveness in treating acquired fibrinogen […]
Verisk Earns Fourth Consecutive Great Place To Work Certification™ in the United Kingdom
LONDON, Feb. 14, 2024 (GLOBE NEWSWIRE) — For the fourth consecutive year, leading global data analytics and technology provider Verisk […]
MW Storage and Fluence partner to deliver their largest joint project in Germany after successful collaboration in Finland and Switzerland
The project, one of the largest in continental Europe, will increase flexibility in the power system and support lower electricity […]
ASML publishes 2023 Annual Reports
ASML publishes 2023 Annual ReportsIntegrated overview of how we continue to create impact with our customers, suppliers and other key […]
NewAmsterdam Pharma Announces Pricing of $175.3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
NAARDEN, the Netherlands and MIAMI, Feb. 13, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the […]
Ohmyhome Announces Pricing of Upsized $4.8 Million Public Offering of Ordinary Shares
Singapore, Feb. 13, 2024 (GLOBE NEWSWIRE) — Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property […]
Foremost Lithium Announces Flow-Through and Non-Flow-Through Private Placements
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 13, […]
TSX News -
mdf commerce reports Third Quarter of Fiscal 2024 Financial Results
Q3 FY2024 revenues of $30.2 million compared to $31.7 million in Q3 FY2023, a decrease of $1.5 million or 4.6% […]
B2Gold Fourth Quarter and Full Year 2023 Financial Results – Conference Call Details
VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or […]
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company’s Compensation Committee […]
